Identification of Metabolites and Metabolic Pathways Related to Treatment with Bufei Yishen Formula in a Rat COPD Model Using HPLC Q-TOF/MS

<div>Pulmonary function and pathology in each experimental rat group. (a) The results of TV, PEF, and EF50 for the three groups during the 32-week study period. (b) Lung histomorphological observations by light microscopy for the three groups at weeks 20 and 32.</div>

Evidence-Based Complementary and Alternative Medicine

fig2

Figure 2

Figure 2: Identification of Metabolites and Metabolic Pathways Related to Treatment with Bufei Yishen Formula in a Rat COPD Model Using HPLC Q-TOF/MS 

Figure 2 | Identification of Metabolites and Metabolic Pathways Related to Treatment with Bufei Yishen Formula in a Rat COPD Model Using HPLC Q-TOF/MS 